Comparing the diagnosis accuracy and efficacy of presepsin (sCD14) and nCD64 in neonatal sepsis: A systematic review and meta-analysis

IF 2.3 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

Clinical Epidemiology and Global Health Pub Date : 2025-02-04 DOI:10.1016/j.cegh.2025.101957

Amit Kumar Mittal , Mamta Patel , Dolat Singh Shekhawat , Pratibha Singh , Kuldeep Singh

{"title":"Comparing the diagnosis accuracy and efficacy of presepsin (sCD14) and nCD64 in neonatal sepsis: A systematic review and meta-analysis","authors":"Amit Kumar Mittal , Mamta Patel , Dolat Singh Shekhawat , Pratibha Singh , Kuldeep Singh","doi":"10.1016/j.cegh.2025.101957","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Neonatal sepsis is a leading cause of morbidity and mortality among newborns, requiring early and accurate diagnosis for effective treatment. sCD14 and nCD64 have emerged as promising biomarkers due to their enhanced sensitivity and specificity compared to traditional methods.</div></div><div><h3>Objective</h3><div>To evaluate and compare the diagnostic accuracy and clinical utility of sCD14 and nCD64 in detecting neonatal sepsis.</div></div><div><h3>Methods</h3><div>A systematic review and meta-analysis were conducted, including studies that assessed the sensitivity, specificity, and overall diagnostic performance of sCD14 and nCD64. Various key metrics such as DOR, PLR, NLR, and AUC were analyzed.</div></div><div><h3>Results</h3><div>Eleven studies with 1303 neonates (777 sepsis cases, 526 controls) were included. For sCD14, the pooled sensitivity was 0.82 (95 % CI: 0.65–0.92), specificity was 0.79 (95 % CI: 0.59–0.91), and AUC was 0.88. For nCD64, pooled sensitivity was 0.84 (95 % CI: 0.78–0.89), specificity was 0.79 (95 % CI: 0.65–0.88), and AUC was 0.89. Both biomarkers demonstrated high diagnostic reliability, with DORs of 18 (sCD14) and 17.04 (nCD64).</div></div><div><h3>Conclusions</h3><div>sCD14 and nCD64 show significant potential as reliable biomarkers for the early diagnosis of neonatal sepsis. High diagnostic accuracy makes them valuable tools for improving clinical decision-making. However, further studies are needed to validate their practical implementation in routine neonatal care, feasibility, and cost-effectiveness.</div></div>","PeriodicalId":46404,"journal":{"name":"Clinical Epidemiology and Global Health","volume":"32 ","pages":"Article 101957"},"PeriodicalIF":2.3000,"publicationDate":"2025-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Epidemiology and Global Health","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213398425000466","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Neonatal sepsis is a leading cause of morbidity and mortality among newborns, requiring early and accurate diagnosis for effective treatment. sCD14 and nCD64 have emerged as promising biomarkers due to their enhanced sensitivity and specificity compared to traditional methods.

Objective

To evaluate and compare the diagnostic accuracy and clinical utility of sCD14 and nCD64 in detecting neonatal sepsis.

Methods

A systematic review and meta-analysis were conducted, including studies that assessed the sensitivity, specificity, and overall diagnostic performance of sCD14 and nCD64. Various key metrics such as DOR, PLR, NLR, and AUC were analyzed.

Results

Eleven studies with 1303 neonates (777 sepsis cases, 526 controls) were included. For sCD14, the pooled sensitivity was 0.82 (95 % CI: 0.65–0.92), specificity was 0.79 (95 % CI: 0.59–0.91), and AUC was 0.88. For nCD64, pooled sensitivity was 0.84 (95 % CI: 0.78–0.89), specificity was 0.79 (95 % CI: 0.65–0.88), and AUC was 0.89. Both biomarkers demonstrated high diagnostic reliability, with DORs of 18 (sCD14) and 17.04 (nCD64).

Conclusions

sCD14 and nCD64 show significant potential as reliable biomarkers for the early diagnosis of neonatal sepsis. High diagnostic accuracy makes them valuable tools for improving clinical decision-making. However, further studies are needed to validate their practical implementation in routine neonatal care, feasibility, and cost-effectiveness.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Epidemiology and Global Health PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-

CiteScore

4.60

自引率

7.70%

发文量

218

审稿时长

66 days

期刊介绍： Clinical Epidemiology and Global Health (CEGH) is a multidisciplinary journal and it is published four times (March, June, September, December) a year. The mandate of CEGH is to promote articles on clinical epidemiology with focus on developing countries in the context of global health. We also accept articles from other countries. It publishes original research work across all disciplines of medicine and allied sciences, related to clinical epidemiology and global health. The journal publishes Original articles, Review articles, Evidence Summaries, Letters to the Editor. All articles published in CEGH are peer-reviewed and published online for immediate access and citation.